Aggregation as well as chemical modification of LDL during oxidation is responsible for poor processing in macrophages.

Aggregation is a characteristic of extensively oxidized (ox-) LDL. We wished to determine whether this structural change contributed even more to the documented poor degradation in macrophages of ox-LDL than the chemical changes. When protein degradation of the soluble and insoluble portions of extensively ox-LDL was compared to that of acetyl LDL in mouse peritoneal macrophages (MPM), we found that the percent of internalized LDL that was degraded was lowest for the insoluble portion (insol. ox-LDL), intermediate for the soluble portion (sol. ox-LDL), and highest for the acetyl LDL, regardless of whether the binding and uptake mechanisms had been excluded, e.g., by performing appropriate pulse-chase studies. As the same order of degradation was found after long-term degradation under cell-free conditions by a mixture of cathepsin B and D, it is likely that poor degradation of ox-LDL by lysosomal proteases is partially responsible for the deficient processing of ox-LDL in MPM. However, when MPM were incubated in a pulse-chase design with LDL that was induced to aggregate by vortexing without oxidizing (vx-LDL), degradation over an 18-h interval of accumulated vx-LDL was almost as low (25%) as that of insol. ox-LDL (18%), in contrast to sol. ox-LDL (60%). Yet, in a cell-free system cathepsin degradation of vx-LDL was as efficient as that of acetyl LDL and LDL. Also, the differences in degradation between sol. and insol. ox-LDL were smaller than in MPM. Thus, it appears that alternative mechanisms to poor proteolysis of substrate were responsible for poor intracellular processing of such aggregated lipoproteins. These results suggest that, although the poorer processing of insol. ox-LDL than sol. ox-LDL may be due, in part, to more deficient proteolytic degradation, particle aggregation per se may play at least as important a role in such deficiencies. This may occur by such mechanisms as altered intracellular trafficking leading to poorer fusion in macrophages of phagosomes containing aggregated lipoproteins with lysosomes.

[1]  R. Dean,et al.  The intracellular storage and turnover of apolipoprotein B of oxidized LDL in macrophages. , 1992, Biochimica et biophysica acta.

[2]  F. Bernini,et al.  Defective catabolism of oxidized LDL by J774 murine macrophages. , 1992, Journal of lipid research.

[3]  H F Hoff,et al.  Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[4]  U. Steinbrecher,et al.  Oxidized low density lipoprotein is resistant to cathepsins and accumulates within macrophages. , 1991, The Journal of biological chemistry.

[5]  H. Hoff,et al.  Macrophage uptake of low-density lipoprotein modified by 4-hydroxynonenal. An ultrastructural study. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[6]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[7]  F. Maxfield,et al.  Endocytosed beta-VLDL and LDL are delivered to different intracellular vesicles in mouse peritoneal macrophages , 1990, The Journal of cell biology.

[8]  S. Ylä-Herttuala,et al.  Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. , 1990, Arteriosclerosis.

[9]  U. Steinbrecher,et al.  Role of oxidatively modified LDL in atherosclerosis. , 1990, Free radical biology & medicine.

[10]  A. Gown,et al.  Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. , 1989, The American journal of pathology.

[11]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[12]  D. Steinberg,et al.  A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. , 1989, The Journal of biological chemistry.

[13]  K. Howell,et al.  Membrane traffic in endocytosis: insights from cell-free assays. , 1989, Annual review of cell biology.

[14]  D. Steinberg,et al.  Enhanced Macrophage Uptake of Low Density Lipoprotein after Self‐Aggregation , 1988, Arteriosclerosis.

[15]  G. Chisolm,et al.  Modification of human serum low density lipoprotein by oxidation--characterization and pathophysiological implications. , 1987, Chemistry and physics of lipids.

[16]  D. Steinberg,et al.  Decrease in Reactive Amino Groups during Oxidation or Endothelial Cell Modification of LDL: Correlation with Changes in Receptor‐Mediated Cataboiism , 1987, Arteriosclerosis.

[17]  H F Hoff,et al.  A low density lipoprotein-sized particle isolated from human atherosclerotic lesions is internalized by macrophages via a non-scavenger-receptor mechanism. , 1986, Journal of lipid research.

[18]  K. H. Carpenter,et al.  Oxidized low density lipoprotein induces ceroid accumulation by murine peritoneal macrophages in vitro. , 1986, Atherosclerosis.

[19]  B. Clevidence,et al.  Cholesterol esterification in macrophages. Stimulation by lipoproteins containing apo B isolated from human aortas. , 1984, Arteriosclerosis.

[20]  M. J. Mitchinson,et al.  Insoluble lipids in human atherosclerotic plaques. , 1982, Atherosclerosis.

[21]  M. Brown,et al.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Bilheimer,et al.  The metabolism of very low density lipoprotein proteins. II. Studies on the transfer of apoproteins between plasma lipoproteins. , 1972, Biochimica et biophysica acta.

[23]  D. Bilheimer,et al.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. , 1972, Biochimica et biophysica acta.

[24]  A. Habeeb,et al.  Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. , 1966, Analytical biochemistry.